Concepts (255)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sodium Channels | 48 | 2015 | 130 | 5.940 |
Why?
|
| Ion Channel Gating | 32 | 2010 | 302 | 3.590 |
Why?
|
| Calcium Channels, T-Type | 9 | 2010 | 24 | 1.920 |
Why?
|
| Lidocaine | 11 | 2015 | 62 | 1.910 |
Why?
|
| Muscle Proteins | 10 | 2015 | 129 | 1.860 |
Why?
|
| Membrane Potentials | 19 | 2013 | 405 | 1.510 |
Why?
|
| Calcium Channel Blockers | 6 | 2010 | 118 | 1.320 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 10 | 2015 | 31 | 1.240 |
Why?
|
| Sodium Channel Blockers | 9 | 2010 | 26 | 1.230 |
Why?
|
| Protein Structure, Tertiary | 16 | 2015 | 729 | 1.020 |
Why?
|
| Anti-Arrhythmia Agents | 4 | 2010 | 76 | 1.000 |
Why?
|
| Myocardium | 14 | 2000 | 570 | 0.870 |
Why?
|
| Asparagine | 3 | 2015 | 28 | 0.770 |
Why?
|
| Spider Venoms | 3 | 2010 | 10 | 0.670 |
Why?
|
| Purkinje Fibers | 13 | 1995 | 27 | 0.660 |
Why?
|
| Peptides | 13 | 2009 | 656 | 0.640 |
Why?
|
| Mibefradil | 3 | 2006 | 3 | 0.640 |
Why?
|
| Kinetics | 24 | 2007 | 1492 | 0.590 |
Why?
|
| Verapamil | 2 | 2010 | 32 | 0.580 |
Why?
|
| Anesthetics, Local | 4 | 2010 | 83 | 0.570 |
Why?
|
| Models, Molecular | 13 | 2011 | 1353 | 0.540 |
Why?
|
| Mutagenesis, Site-Directed | 15 | 2010 | 274 | 0.530 |
Why?
|
| Sodium | 12 | 2010 | 329 | 0.520 |
Why?
|
| Cell Line | 18 | 2010 | 2464 | 0.520 |
Why?
|
| Arginine | 7 | 2013 | 141 | 0.490 |
Why?
|
| Patch-Clamp Techniques | 13 | 2013 | 378 | 0.490 |
Why?
|
| Calcium Channels | 2 | 2011 | 180 | 0.450 |
Why?
|
| Heart | 9 | 2004 | 522 | 0.430 |
Why?
|
| Electric Conductivity | 12 | 2010 | 142 | 0.370 |
Why?
|
| Calcium | 10 | 2000 | 1176 | 0.370 |
Why?
|
| Electrophysiology | 16 | 2006 | 390 | 0.370 |
Why?
|
| Animals | 53 | 2015 | 28155 | 0.350 |
Why?
|
| Transfection | 10 | 2009 | 880 | 0.340 |
Why?
|
| Dogs | 21 | 2000 | 634 | 0.340 |
Why?
|
| Amino Acid Substitution | 7 | 2015 | 331 | 0.340 |
Why?
|
| Dose-Response Relationship, Drug | 10 | 2010 | 1914 | 0.340 |
Why?
|
| Benzocaine | 2 | 2009 | 2 | 0.330 |
Why?
|
| Cardiac Electrophysiology | 1 | 2010 | 11 | 0.330 |
Why?
|
| Connexins | 3 | 2009 | 206 | 0.320 |
Why?
|
| Amino Acid Sequence | 13 | 2015 | 2012 | 0.320 |
Why?
|
| Molecular Sequence Data | 13 | 2015 | 2910 | 0.300 |
Why?
|
| Binding Sites | 11 | 2009 | 1133 | 0.300 |
Why?
|
| Cardiology | 1 | 2010 | 120 | 0.300 |
Why?
|
| Cnidarian Venoms | 5 | 2006 | 19 | 0.290 |
Why?
|
| Recombinant Proteins | 9 | 2004 | 988 | 0.290 |
Why?
|
| Rats | 16 | 2015 | 4072 | 0.290 |
Why?
|
| Protein Conformation | 7 | 2010 | 914 | 0.280 |
Why?
|
| Ethyl Methanesulfonate | 2 | 2005 | 4 | 0.280 |
Why?
|
| Cardiotonic Agents | 4 | 1996 | 88 | 0.270 |
Why?
|
| Structure-Activity Relationship | 6 | 2011 | 422 | 0.270 |
Why?
|
| Purkinje Cells | 4 | 1993 | 86 | 0.270 |
Why?
|
| Cell Membrane | 3 | 2008 | 664 | 0.260 |
Why?
|
| Atrial Natriuretic Factor | 3 | 1991 | 38 | 0.260 |
Why?
|
| Myocardial Contraction | 4 | 1998 | 188 | 0.260 |
Why?
|
| Venoms | 1 | 2006 | 11 | 0.250 |
Why?
|
| Humans | 37 | 2015 | 93511 | 0.240 |
Why?
|
| Mesylates | 4 | 2010 | 14 | 0.240 |
Why?
|
| Oocytes | 2 | 2009 | 211 | 0.220 |
Why?
|
| Polyamines | 1 | 2004 | 37 | 0.210 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 11 | 2004 | 192 | 0.210 |
Why?
|
| Muscle, Skeletal | 5 | 2006 | 474 | 0.210 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 751 | 0.200 |
Why?
|
| Endocytosis | 2 | 1994 | 184 | 0.190 |
Why?
|
| Molecular Structure | 4 | 2010 | 307 | 0.190 |
Why?
|
| Cations, Divalent | 2 | 1992 | 36 | 0.190 |
Why?
|
| Lanthanum | 2 | 1992 | 16 | 0.190 |
Why?
|
| Kidney | 2 | 2004 | 1111 | 0.180 |
Why?
|
| Models, Biological | 5 | 2008 | 1768 | 0.170 |
Why?
|
| In Vitro Techniques | 10 | 2002 | 948 | 0.170 |
Why?
|
| HEK293 Cells | 2 | 2015 | 696 | 0.170 |
Why?
|
| Insecticides | 1 | 2000 | 26 | 0.170 |
Why?
|
| Point Mutation | 1 | 2000 | 238 | 0.160 |
Why?
|
| Toxins, Biological | 1 | 1999 | 8 | 0.150 |
Why?
|
| Protein Structure, Secondary | 5 | 2011 | 337 | 0.150 |
Why?
|
| Saxitoxin | 5 | 2000 | 8 | 0.140 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 1996 | 15 | 0.120 |
Why?
|
| Cyclic AMP | 2 | 1995 | 276 | 0.120 |
Why?
|
| Drosophila melanogaster | 1 | 2000 | 630 | 0.120 |
Why?
|
| Porosity | 1 | 2015 | 64 | 0.120 |
Why?
|
| Colforsin | 1 | 1995 | 69 | 0.110 |
Why?
|
| Extracellular Space | 3 | 2010 | 88 | 0.110 |
Why?
|
| Isoquinolines | 1 | 1994 | 57 | 0.110 |
Why?
|
| Chymotrypsin | 1 | 1993 | 28 | 0.100 |
Why?
|
| Mutation | 5 | 2008 | 4272 | 0.100 |
Why?
|
| Potassium Channels | 2 | 2011 | 346 | 0.100 |
Why?
|
| Electrochemistry | 3 | 2000 | 60 | 0.100 |
Why?
|
| Scorpion Venoms | 2 | 2006 | 25 | 0.100 |
Why?
|
| Sea Anemones | 5 | 2006 | 16 | 0.100 |
Why?
|
| Biophysics | 3 | 2006 | 153 | 0.100 |
Why?
|
| Cells, Cultured | 5 | 2004 | 2850 | 0.090 |
Why?
|
| Heart Conduction System | 6 | 1988 | 133 | 0.090 |
Why?
|
| Phenylalanine | 2 | 2009 | 32 | 0.090 |
Why?
|
| Barium | 3 | 2000 | 32 | 0.090 |
Why?
|
| Casein Kinase Idelta | 1 | 2011 | 2 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2006 | 493 | 0.090 |
Why?
|
| Mechanoreceptors | 1 | 1991 | 18 | 0.090 |
Why?
|
| Heart Atria | 4 | 1994 | 248 | 0.090 |
Why?
|
| Gap Junctions | 2 | 2009 | 146 | 0.080 |
Why?
|
| Protein Isoforms | 3 | 2011 | 295 | 0.080 |
Why?
|
| Receptors, AMPA | 1 | 2011 | 67 | 0.080 |
Why?
|
| Biotin | 2 | 2009 | 44 | 0.080 |
Why?
|
| Biophysical Phenomena | 2 | 2002 | 124 | 0.080 |
Why?
|
| Nucleus Accumbens | 1 | 2011 | 113 | 0.080 |
Why?
|
| Amphetamine | 1 | 2011 | 101 | 0.080 |
Why?
|
| Ion Channels | 6 | 2008 | 256 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2010 | 187 | 0.080 |
Why?
|
| Static Electricity | 3 | 2007 | 94 | 0.070 |
Why?
|
| Cysteine | 2 | 2007 | 145 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2010 | 314 | 0.070 |
Why?
|
| Motor Activity | 1 | 2011 | 323 | 0.070 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2010 | 225 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 4 | 1999 | 1028 | 0.070 |
Why?
|
| Electric Stimulation | 2 | 2000 | 344 | 0.070 |
Why?
|
| Spiders | 1 | 2008 | 17 | 0.070 |
Why?
|
| Gene Expression | 2 | 2005 | 1301 | 0.070 |
Why?
|
| Alternative Splicing | 2 | 2006 | 219 | 0.070 |
Why?
|
| Brain | 2 | 2006 | 2391 | 0.070 |
Why?
|
| Magnesium | 3 | 1992 | 173 | 0.070 |
Why?
|
| Voltage-Gated Sodium Channel beta-3 Subunit | 1 | 2006 | 1 | 0.060 |
Why?
|
| NAV1.3 Voltage-Gated Sodium Channel | 1 | 2006 | 1 | 0.060 |
Why?
|
| Cell Membrane Permeability | 1 | 2007 | 121 | 0.060 |
Why?
|
| Calcium Channels, L-Type | 1 | 2006 | 38 | 0.060 |
Why?
|
| Protons | 1 | 2006 | 102 | 0.060 |
Why?
|
| Marine Toxins | 2 | 1996 | 4 | 0.060 |
Why?
|
| Sulfhydryl Reagents | 1 | 2005 | 9 | 0.060 |
Why?
|
| Papillary Muscles | 3 | 1999 | 17 | 0.060 |
Why?
|
| Epilepsy, Generalized | 1 | 2006 | 42 | 0.060 |
Why?
|
| Lysine | 2 | 2007 | 182 | 0.060 |
Why?
|
| Sarcoplasmic Reticulum | 2 | 1998 | 25 | 0.060 |
Why?
|
| Tetrodotoxin | 4 | 1993 | 49 | 0.060 |
Why?
|
| Polyelectrolytes | 1 | 2004 | 5 | 0.060 |
Why?
|
| Xenopus laevis | 1 | 2004 | 137 | 0.050 |
Why?
|
| Serine | 1 | 2004 | 105 | 0.050 |
Why?
|
| Time Factors | 6 | 1995 | 5410 | 0.050 |
Why?
|
| Glycine | 1 | 2003 | 93 | 0.050 |
Why?
|
| Nickel | 2 | 1992 | 14 | 0.050 |
Why?
|
| Cobalt | 2 | 1992 | 31 | 0.050 |
Why?
|
| Cadmium | 2 | 1992 | 29 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2004 | 470 | 0.050 |
Why?
|
| Genetic Variation | 2 | 2006 | 1415 | 0.050 |
Why?
|
| Manganese | 2 | 1992 | 56 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 665 | 0.050 |
Why?
|
| RNA | 1 | 2006 | 573 | 0.040 |
Why?
|
| Zinc | 2 | 1992 | 99 | 0.040 |
Why?
|
| Rabbits | 2 | 1993 | 618 | 0.040 |
Why?
|
| Rats, Inbred Strains | 2 | 1991 | 304 | 0.040 |
Why?
|
| Insecticide Resistance | 1 | 2000 | 8 | 0.040 |
Why?
|
| Protein Binding | 3 | 2004 | 1534 | 0.040 |
Why?
|
| Isoproterenol | 2 | 1993 | 57 | 0.040 |
Why?
|
| Temperature | 2 | 2000 | 424 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2004 | 1118 | 0.040 |
Why?
|
| Indicators and Reagents | 1 | 2000 | 69 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2011 | 1245 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 2000 | 152 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 2 | 1999 | 555 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 587 | 0.040 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 1999 | 81 | 0.040 |
Why?
|
| Glutamic Acid | 2 | 2011 | 147 | 0.040 |
Why?
|
| Long QT Syndrome | 1 | 1999 | 37 | 0.040 |
Why?
|
| Sarcolemma | 1 | 1998 | 30 | 0.030 |
Why?
|
| Cats | 3 | 1988 | 285 | 0.030 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 1998 | 24 | 0.030 |
Why?
|
| Neuroblastoma | 2 | 1999 | 396 | 0.030 |
Why?
|
| Isomerism | 1 | 1997 | 28 | 0.030 |
Why?
|
| Chimera | 1 | 1997 | 52 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2009 | 517 | 0.030 |
Why?
|
| Markov Chains | 1 | 1998 | 135 | 0.030 |
Why?
|
| United States | 1 | 2010 | 7619 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2006 | 1117 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 1998 | 191 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 1996 | 894 | 0.030 |
Why?
|
| Xenopus | 2 | 2009 | 119 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 887 | 0.030 |
Why?
|
| Neurotoxins | 1 | 1996 | 44 | 0.030 |
Why?
|
| Cell Fusion | 1 | 1996 | 34 | 0.030 |
Why?
|
| Methods | 1 | 1996 | 139 | 0.030 |
Why?
|
| Mammals | 1 | 1999 | 259 | 0.030 |
Why?
|
| Systole | 2 | 1987 | 83 | 0.030 |
Why?
|
| Leucine | 1 | 1996 | 56 | 0.030 |
Why?
|
| Tryptophan | 1 | 1996 | 105 | 0.030 |
Why?
|
| Alanine | 2 | 2008 | 83 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1996 | 244 | 0.030 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 1995 | 111 | 0.030 |
Why?
|
| Coated Pits, Cell-Membrane | 1 | 1994 | 7 | 0.030 |
Why?
|
| Oxazoles | 1 | 1994 | 13 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 1994 | 88 | 0.030 |
Why?
|
| Circular Dichroism | 2 | 2009 | 117 | 0.030 |
Why?
|
| Models, Cardiovascular | 2 | 1992 | 92 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1994 | 291 | 0.030 |
Why?
|
| Caffeine | 1 | 1994 | 85 | 0.030 |
Why?
|
| Sucrose | 1 | 1993 | 64 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 1993 | 163 | 0.020 |
Why?
|
| Thionucleotides | 1 | 1993 | 54 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 1999 | 813 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 1994 | 257 | 0.020 |
Why?
|
| Base Sequence | 3 | 2006 | 2220 | 0.020 |
Why?
|
| Brefeldin A | 1 | 1991 | 10 | 0.020 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1991 | 35 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1992 | 168 | 0.020 |
Why?
|
| Biological Availability | 1 | 1992 | 86 | 0.020 |
Why?
|
| Cyclopentanes | 1 | 1991 | 27 | 0.020 |
Why?
|
| DNA | 1 | 1997 | 1265 | 0.020 |
Why?
|
| Cell Separation | 1 | 1992 | 200 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1991 | 439 | 0.020 |
Why?
|
| Golgi Apparatus | 1 | 1991 | 115 | 0.020 |
Why?
|
| Permeability | 1 | 1991 | 143 | 0.020 |
Why?
|
| Isometric Contraction | 2 | 1988 | 34 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 1991 | 260 | 0.020 |
Why?
|
| Phenotype | 1 | 1996 | 2544 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 1133 | 0.020 |
Why?
|
| Phenothiazines | 1 | 1988 | 3 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2008 | 209 | 0.020 |
Why?
|
| Microcomputers | 1 | 1987 | 25 | 0.020 |
Why?
|
| Cell Communication | 1 | 2008 | 216 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2007 | 66 | 0.020 |
Why?
|
| Veratridine | 2 | 1996 | 2 | 0.020 |
Why?
|
| Acidosis | 1 | 2006 | 53 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2006 | 113 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2006 | 384 | 0.010 |
Why?
|
| Diastole | 1 | 1985 | 99 | 0.010 |
Why?
|
| DNA Primers | 2 | 1996 | 531 | 0.010 |
Why?
|
| Mice | 4 | 2003 | 12269 | 0.010 |
Why?
|
| Female | 3 | 1993 | 48698 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1985 | 194 | 0.010 |
Why?
|
| NAV1.2 Voltage-Gated Sodium Channel | 1 | 2003 | 5 | 0.010 |
Why?
|
| Exercise | 1 | 2006 | 353 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 1987 | 650 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2003 | 502 | 0.010 |
Why?
|
| Action Potentials | 3 | 1989 | 581 | 0.010 |
Why?
|
| Signal Transduction | 1 | 1991 | 3502 | 0.010 |
Why?
|
| Male | 2 | 2011 | 44553 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2003 | 2755 | 0.010 |
Why?
|
| Genes, Synthetic | 1 | 1996 | 7 | 0.010 |
Why?
|
| Isoleucine | 1 | 1996 | 18 | 0.010 |
Why?
|
| Perfusion | 2 | 1987 | 260 | 0.010 |
Why?
|
| Solubility | 1 | 1996 | 187 | 0.010 |
Why?
|
| Tetraethylammonium Compounds | 1 | 1995 | 13 | 0.010 |
Why?
|
| Delayed Rectifier Potassium Channels | 1 | 1995 | 13 | 0.010 |
Why?
|
| Tetraethylammonium | 1 | 1995 | 23 | 0.010 |
Why?
|
| Shab Potassium Channels | 1 | 1995 | 20 | 0.010 |
Why?
|
| Cations | 1 | 1995 | 29 | 0.010 |
Why?
|
| Shaker Superfamily of Potassium Channels | 1 | 1995 | 43 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1995 | 164 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1995 | 141 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 404 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1995 | 410 | 0.010 |
Why?
|
| Forecasting | 1 | 1990 | 293 | 0.000 |
Why?
|
| Quinidine | 1 | 1988 | 11 | 0.000 |
Why?
|
| Moricizine | 1 | 1988 | 2 | 0.000 |
Why?
|
| Neurons | 1 | 1996 | 1582 | 0.000 |
Why?
|
| Decapodiformes | 1 | 1987 | 46 | 0.000 |
Why?
|
| Axons | 1 | 1987 | 179 | 0.000 |
Why?
|
| Thermodynamics | 1 | 1987 | 325 | 0.000 |
Why?
|
| Homeostasis | 1 | 1988 | 460 | 0.000 |
Why?
|
| Reaction Time | 1 | 1986 | 317 | 0.000 |
Why?
|